179 related articles for article (PubMed ID: 26930753)
21. The role of COX-2 in oral cancer development, and chemoprevention/ treatment of oral cancer by selective COX-2 inhibitors.
Wang Z
Curr Pharm Des; 2005; 11(14):1771-7. PubMed ID: 15892674
[TBL] [Abstract][Full Text] [Related]
22. Chemoprevention of lung cancer.
Benner SE; Lippman SM; Hong WK
Chest; 1995 Jun; 107(6 Suppl):316S-321S. PubMed ID: 7781413
[TBL] [Abstract][Full Text] [Related]
23. Not significant but important.
Mulshine JL; Ondrey FG
Cancer Prev Res (Phila); 2013 May; 6(5):371-4. PubMed ID: 23639860
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of oral carcinogenesis by a protease inhibitor.
Messadi DV; Billings P; Shklar G; Kennedy AR
J Natl Cancer Inst; 1986 Mar; 76(3):447-52. PubMed ID: 3081747
[TBL] [Abstract][Full Text] [Related]
25. Chemoprevention of oral cancer: A review and future perspectives.
Liao YH; Chou WY; Chang CW; Lin MC; Wang CP; Lou PJ; Chen TC
Head Neck; 2023 Apr; 45(4):1045-1059. PubMed ID: 36810813
[TBL] [Abstract][Full Text] [Related]
26. [Current status and prospects of chemoprevention in oral squamous epithelial carcinomas and precancerous lesions].
Zöller JE; Scheer M
Mund Kiefer Gesichtschir; 2000 May; 4 Suppl 1():S160-8. PubMed ID: 10938656
[TBL] [Abstract][Full Text] [Related]
27. Role of gap-junctional communication in breast cancer progression and chemoprevention.
Sawey MJ
J Nutr; 2001 Jan; 131(1):167S-169S. PubMed ID: 11208957
[No Abstract] [Full Text] [Related]
28. Thalidomide: features and potential significance in oral precancerous conditions and oral cancer.
Jin X; Lu S; Xing X; Wang L; Mu D; He M; Huang H; Zeng X; Chen Q
J Oral Pathol Med; 2013 May; 42(5):355-62. PubMed ID: 22978368
[TBL] [Abstract][Full Text] [Related]
29. Chemopreventive potential of flavonoids in oral squamous cell carcinoma in human studies.
Iriti M; Varoni EM
Nutrients; 2013 Jul; 5(7):2564-76. PubMed ID: 23857227
[TBL] [Abstract][Full Text] [Related]
30. Other novel agents: Rationale and current status as chemopreventive agents.
Tolcher AW; Kennedy A; Padley RJ; Majeed N; Pollak M; Kantoff PW
Urology; 2001 Apr; 57(4 Suppl 1):86-9. PubMed ID: 11295602
[TBL] [Abstract][Full Text] [Related]
31. Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection.
Bauman JE; Grandis J
JAMA Oncol; 2016 Feb; 2(2):178-9. PubMed ID: 26540592
[No Abstract] [Full Text] [Related]
32. Chemoprevention of oral cancer: the need for effective biological monitoring.
Pillai MR; Ravi D; Nair MK
Singapore Dent J; 1997 Aug; 22(1):6-12. PubMed ID: 10597170
[TBL] [Abstract][Full Text] [Related]
33. Cancer prevention by protease inhibitors.
Kennedy AR
Prev Med; 1993 Sep; 22(5):796-811. PubMed ID: 8234219
[TBL] [Abstract][Full Text] [Related]
34. [Biological aspects and perspectives applicable to the chemoprevention of cancer of the upper respiratory-digestive tract].
Toma S; Coialbu T; Collecchi P; Cavallari M; Bacigalupo A; Michelotti A; Albanese E; Giacchero A; Cantoni E; Merlano M
Acta Otorhinolaryngol Ital; 1990; 10 Suppl 27():41-54. PubMed ID: 2203223
[TBL] [Abstract][Full Text] [Related]
35. Retinoids in chemoprevention of head and neck carcinogenesis.
Lippman SM; Benner SE; Hong WK
Prev Med; 1993 Sep; 22(5):693-700. PubMed ID: 8234209
[TBL] [Abstract][Full Text] [Related]
36. Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.
Armstrong WB; Taylor TH; Kennedy AR; Melrose RJ; Messadi DV; Gu M; Le AD; Perloff M; Civantos F; Goodwin WJ; Wirth LJ; Kerr AR; Meyskens FL
Cancer Prev Res (Phila); 2013 May; 6(5):410-8. PubMed ID: 23639862
[TBL] [Abstract][Full Text] [Related]
37. Current status of retinoids in chemoprevention of oral squamous cell carcinoma: an overview.
Conley BA; Ord RA
J Craniomaxillofac Surg; 1996 Dec; 24(6):339-45. PubMed ID: 9032601
[TBL] [Abstract][Full Text] [Related]
38. Retinoids and carotenoids in the prevention of oral cancer: a critical appraisal.
Garewal HS; Meyskens F
Cancer Epidemiol Biomarkers Prev; 1992; 1(2):155-9. PubMed ID: 1306099
[No Abstract] [Full Text] [Related]
39. Pleiotrophic effects of natural products in ROS-induced carcinogenesis: the role of plant-derived natural products in oral cancer chemoprevention.
Ziech D; Anestopoulos I; Hanafi R; Voulgaridou GP; Franco R; Georgakilas AG; Pappa A; Panayiotidis MI
Cancer Lett; 2012 Dec; 327(1-2):16-25. PubMed ID: 22381695
[TBL] [Abstract][Full Text] [Related]
40. Differential response of normal, premalignant and malignant human oral epithelial cells to growth inhibition by chemopreventive agents.
D'Ambrosio SM; Gibson-D'Ambrosio R; Milo GE; Casto B; Kelloff GJ; Steele VE
Anticancer Res; 2000; 20(4):2273-80. PubMed ID: 10953285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
